Bruker (BRKR) FCF Payout Ratio Growth (3y) (2018 - 2026)
Bruker (BRKR) FCF Payout Ratio Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -24.36% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -15.73% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.06% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 47.27% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -478.95% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.49% |
| 10 | Bruker | 9.13 Bn | 9.13 Bn | 416.00 Mn | -35.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.21% |
| Mar 31, 2026 | 10.95% |
| Dec 31, 2025 | -12.51% |
| Sep 30, 2025 | -30.53% |
| Jun 30, 2025 | 24.86% |
| Mar 31, 2025 | 15.68% |
| Dec 31, 2024 | -3.08% |
| Sep 30, 2024 | 17.75% |
| Jun 30, 2024 | 66.31% |
| Mar 31, 2024 | 503.04% |
| Dec 31, 2023 | 34.30% |
| Sep 30, 2023 | 65.06% |
| Jun 30, 2023 | 72.03% |
| Mar 31, 2023 | -23.71% |
| Dec 31, 2022 | -1.99% |
| Sep 30, 2022 | 54.13% |
| Jun 30, 2022 | 47.90% |
| Mar 31, 2022 | -58.23% |
| Dec 31, 2021 | 32.77% |
| Sep 30, 2021 | 143.05% |